R&D Systems™ Recombinant Human IGSF8/CD316 Fc Chimera Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems™ 1241S8050
DescriptionThe Recombinant Human IGSF8/CD316 Fc Chimera Protein is derived from HEK293. The Recombinant Human IGSF8/CD316 Fc Chimera Protein has been validated for the following applications: Bioactivity.
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.|
|Human embryonic kidney cell,HEK293-derived human IGSF8/CD316 protein, (N-terminus) Human IGSF8 (Arg28-Thr579) Accession &Num; Q969P0-1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)|
|Reconstitute at 500 μg/mL in PBS.|
|12 months from date of receipt, <= -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.|
|<0.10 EU per 1 μg of the protein by the LAL method.|
|Lyophilized from a 0.2 μm filtered solution in PBS.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok